自动化膜片钳数据改善SCN5A-Brugada综合征变异分类与外显率分层
本研究对来自3335例Brugada综合征患者队列的252个SCN5A错义及框内插入/缺失变异,采用校准的高通量自动化膜片钳(APC)功能测定进行功能评估。结果显示146个变异功能异常,其中100个为严重功能丧失;功能证据使225个意义不明变异中的110个得以重新分类。
要点
- APC功能测定可对SCN5A变异进行功能分层,区分正常功能「旁观者」变异与功能丧失变异。
- 功能证据可整合其他标准重新分类约半数意义不明变异。
- SCN5A变异外显率与功能丧失严重程度成正比。
核心结论
- 队列规模的APC数据集可将Brugada综合征患者的SCN5A变异分为低风险的正常功能「旁观者」变异和高风险的功能丧失变异。
- 功能数据可与其他标准整合,重新分类相当比例的意义不明变异。
- 该数据集有助于阐明SCN5A-Brugada综合征关系,并改善先证者及其家族的诊断与临床管理。
研究设计与样本
- 研究分析了来自既往发表的大型Brugada综合征病例队列(n=3335例患者)的全部252个SCN5A错义及框内插入/缺失变异。
- 采用校准的高通量自动化膜片钳(APC)功能测定进行功能评估。
- 变异功能Z评分按美国医学遗传学与基因组学学会(ACMG)标准赋予证据等级,从BS3_moderate(功能正常)到PS3_strong(功能丧失)。
- 功能证据与人群频率、热点、病例计数、蛋白长度变化及计算机预测相结合。
- Brugada综合征病例对照富集比值比和外显率根据Brugada综合征队列与gnomAD中的变异频率计算。
主要发现
- 大多数变异(146/252)功能异常(Z≤-2),其中100个为严重功能丧失(Z≤-4)。
- 功能证据使225个意义不明变异中的110个得以重新分类,其中104个重新分类为可能致病,6个为可能良性。
- SCN5A功能丧失变异主要定位于跨膜结构域,尤其是构成中央孔的区域。
关键数值与推荐
- 功能异常定义为Z≤-2,严重功能丧失定义为Z≤-4。
- ACMG证据等级从BS3_moderate(功能正常)到PS3_strong(功能丧失)。
临床怎么用
- 对于Brugada综合征患者中检出的SCN5A意义不明变异,可借助APC功能测定数据辅助重新分类。
- 功能丧失严重的SCN5A变异与较高的Brugada综合征外显率相关,可能有助于风险分层。
- 功能正常的「旁观者」变异Brugada综合征风险低,可减少不必要的临床干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Brugada Syndrome (BrS) is an inherited arrhythmia disorder that causes an elevated risk of sudden cardiac death. Approximately 20% of patients with BrS have rare variants in SCN5A, which encodes the cardiac sodium channel NaV1.5. Genetic workup of BrS is often complicated by SCN5A variants of uncertain significance (VUS) and/or incomplete penetrance. This study deployed an SCN5A-BrS functional assay at cohort scale to facilitate the implementation of genetic and precision medicine. METHODS: All 252 missense and in-frame insertion/deletion SCN5A variants from a previously published large cohort of BrS cases (n = 3335 patients) were analysed using a calibrated high-throughput automated patch-clamp (APC) assay. Variant functional Z-scores were assigned evidence levels ranging from BS3_moderate (normal function) to PS3_strong (loss-of-function), as defined by American College of Medical Genetics and Genomics criteria. Functional evidence was combined with population frequency, hotspot, case counts, protein-length changes, and in silico predictions. Odds ratios of BrS case-control enrichment and penetrance for BrS were calculated from variant frequencies in the BrS cohort and in gnomAD. RESULTS: Most variants (146/252) were functionally abnormal (Z ≤ -2), with 100 having severe loss-of-function (Z ≤ -4). Functional evidence enabled the reclassification of 110 of 225 VUS; 104 to likely pathogenic and 6 to likely benign. SCN5A variants with loss-of-function were mainly localized to the transmembrane domains, especially the regions comprising the central pore. SCN5A variant penetrance was proportional to the severity of loss-of-function; variants with Z ≤ -6 had penetrance of 24.5% (15.9%-37.7% CI) and an odds ratio of 501 for BrS. CONCLUSIONS: This cohort-scale APC dataset stratifies SCN5A variants found in BrS patients into normal function 'bystander' variants that have a low risk of BrS and loss-of-function variants that have a high risk for BrS. Functional data can be integrated with other criteria to reclassify a substantial fraction of VUS. The dataset helps clarify the SCN5A-BrS relationship and will improve the diagnosis and clinical management of BrS probands and their families.
引用
- O'Neill MJ, Ma JG, Aldridge JL, et al. Automated patch clamp data improve variant classification and penetrance stratification for SCN5A-Brugada syndrome. Eur Heart J. 2026. PMID: 41251004. doi:10.1093/eurheartj/ehaf874
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。